Valeant to Borrow About $7 Billion for Bausch & Lomb Buyout

Valeant Pharmaceuticals International Inc. said it secured debt financing from Goldman Sachs Group Inc. for $6.7 billion to $7.2 billion for its buyout of Bausch & Lomb Holdings Inc. Montreal-based Valeant will pay $4.5 billion for the eye-care company and spend $4.2 billion to repay Bausch & Lomb’s debt, the companies said in a statement. The deal will bring Valeant’s debt as a ratio of earnings before interest, taxes, depreciation and amortization to 4.6 times, according to the statement.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE